Achilles tendon volume in type 2 Diabetic Patients with or without Peripheral Neuropathy: MRI Study

Abstract

The aim of this study was to evaluate Achilles tendon (AT) in type 2 diabetic patients with vs. without peripheral neuropathy using Magnetic Resonance Imaging (MRI). The study included 19 patients (group A, mean age 63.9±7.4 years) with peripheral neuropathy and 19 patients (group B, mean age 63.6±6.1 years) without peripheral neuropathy, as well as 16 healthy controls (group C, mean age 61.6±8.4 years). Neuropathy was diagnosed by the Diabetic Neuropathy Index (DNI). The maximum AT thickness and AT volume were measured on sagittal T₁ weighted MRI images. AT volume was calculated by the sum of the tendon surface area of all contiguous sections multiplied by the slice thickness. Diabetic patients had significantly (p<0.001) greater AT volume than controls (9742.0±2034.9 mm³ vs. 7323.8±1918.2 mm³). This difference was observed both in men (p=0.030) and in women (p<0.001). AT volume was significantly greater in group A vs. C (p=0.003) and in group B vs. C (p<0.001), but there was no difference between groups A and B (p=0.469). Finally, in group A increased AT volume was significantly (p=0.041) associated with clinical severity of neuropathy.

Conclusions Type 2 diabetic patients have increased AT volume as compared to controls. There is no difference in AT volume between patients with and without neuropathy. However, in neuropathic patients increased AT volume is associated with severity of neuropathy.

Key words

Achilles tendon - diabetes mellitus - diabetic foot - diabetic neuropathy - MRI - volume measurements

References

• 1 Akturk M, Ozdemir A, Maral I. et al . Evaluation of Achilles tendon thickening in type 2 diabetes mellitus.  Exp Clin Endocrinol Diabetes. 2007;  115 92-96
• 2 Batista F, Nery C, Pinzur M. et al . Achilles tendinopathy in diabetes mellitus.  Foot Ankle Int. 2008;  29 498-501
• 3 Boulton AJM, Kirsner RS, Vileikyte L. Neuropathic diabetic foot ulcers.  N Engl J Med. 2004;  351 48-55
• 4 Boulton AJ, Vinik AI, Arezzo JC. et al . Diabetic neuropathies: a statement by the American Diabetes Association.  Diabetes Care. 2005;  28 956-962
• 5 Cameron NE, Gibson TM, Nangle MR. et al . Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes.  Ann NY Acad Sci. 2005;  1043 784-792
• 6 Cumbie BC, Hermayer KL. Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications.  Vasc Health Risk Manag. 2007;  3 823-832
• 7 Dussault RG, Kaplan PA, Roederer G. MR imaging of Achilles tendon in patients with familial hyperlipidemia: comparison with plain films, physical examination and patients with traumatic tendon lesions.  Am J Roentgenol. 1995;  164 403-407
• 8 Edmonds M. The diabetic foot, 2003.  Diabetes Metab Res Rev. 2004;  20 ((Suppl 1)) S9-S12
• 9 Feldman EL, Stevens MJ, Thomas PK. et al . A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy.  Diabetes Care. 1994;  17 1281-1289
• 10 Giacomozzi C, Caselli A, Macellari V. et al . Walking strategy in diabetic patients with peripheral neuropathy.  Diabetes Care. 2002;  25 1451-1457
• 11 Giacomozzi C, D’Ambrogi E, Uccioli L. et al . Does the thickening of Achilles tendon and plantar fascia contribute to the alteration of diabetic foot loading?.  Clin Biomech. 2005;  20 532-539
• 12 Grant WP, Sullivan R, Sonenshine DE. et al . Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon.  J Foot Ankle Surg. 1997;  36 272-278
• 13 Haims AH, Schweitzer ME, Patel RS. et al . MR imaging of the Achilles tendon: overlap of findings in symptomatic and asymptomatic individuals.  Skeletal Radiol. 2000;  29 640-645
• 14 Movin T, Kristoffersen-Wiberg M, Rolf C. et al . MR imaging in chronic Achilles tendon disorder.  Acta Radiol. 1998;  39 126-132
• 15 Mueller MJ, Maluf KS. Tissue adaptation to physical stress: a proposed “Physical Stress Theory” to guide physical therapist practice, education, and research.  Phys Ther. 2002;  82 383-403
• 16 Nishimoto GS, Attinger CE, Cooper PS. Lengthening the Achilles tendon for the treatment of diabetic plantar forefoot ulceration.  Surg Clin North Am. 2003;  83 707-726
• 17 Papanas N, Papatheodorou K, Christakidis. et al . Evaluation of a new indicator test for sudomotor function (Neuropad^®) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.  Exp Clin Endocrinol Diabetes. 2005;  113 195-198
• 18 Papanas N, Gries A, Maltezos E. et al . The steel ball-bearing test: a new test for evaluating protective sensation in the diabetic foot.  Diabetologia. 2006;  49 739-743
• 19 Papanas N, Maltezos E. The diabetic foot: established and emerging treatments.  Acta Clin Belg. 2007;  62 230-238
• 20 Reddy GK. Cross-linking in collagen by nonenzymatic glycation increases the matrix stiffness in rabbit achilles tendon.  Exp Diabesity Res. 2004;  5 143-153
• 21 Reiber GE, Ledoux WR. Epidemiology of diabetic foot ulcers and complications: evidence for prevention. In: Williams R, Herman W, Kinmoth AL, Wareham NJ (Eds) the evidence base for diabetes care. Chichester: Wiley 2002: 641-665
• 22 Seifarth CC, Hinkmann C, Hahn EG. et al . Reduced frequency of peripheral dendritic cells in type 2 diabetes.  Exp Clin Endocrinol Diabetes. 2008;  116 162-166
• 23 Tentolouris N, Achtsidis V, Marinou K. et al . Evaluation of the self-administered indicator plaster Neuropad for the diagnosis of neuropathy in diabetes.  Diabetes Care. 2008;  31 236-237
• 24 van Schie CH, Vermigli C, Carrington AL. et al . Muscle weakness and foot deformities in diabetes: relationship to neuropathy and foot ulceration in caucasian diabetic men.  Diabetes Care. 2004;  27 1668-1673
• 25 van Schie CH. A review of the biomechanics of the diabetic foot.  Int J Low Extrem Wounds. 2005;  4 160-170
• 26 Várkonyi T, Kempler P. Diabetic neuropathy: new strategies for treatment.  Diabetes Obes Metab. 2008;  10 99-108
• 27 Veves A, Manes C, Murray HJ. et al . Painful neuropathy and foot ulceration in diabetic patients.  Diabetes Care. 1993;  16 1187-1189
• 28 Ziegler D, Siekierka-Kleiser E, Meyer B. et al . Validation of a novel screening device (NeuroQuick) for quantitative assessment of small fiber dysfunction as an early feature of diabetic polyneuropathy.  Diabetes Care. 2005;  28 1169-1174
• 29 Zimny S, Pfohl M. Healing times and prediction of wound healing in neuropathic diabetic foot ulcers: a prospective study.  Exp Clin Endocrinol Diabetes. 2005;  113 90-93

Correspondence